Throne Biotechnologies

Biotechnology ResearchNew Jersey, United States2-10 Employees

Throne Biotechnologies is a clinical-stage biotechnology company focused on stem cell–based immune therapies designed to address autoimmune diseases, with the aim of restoring immune balance and islet beta-cell function in type 1 diabetes and related conditions. The company uses a cord blood–derived multipotent stem cell technology to educate a patient’s own immune system by circulating blood through a system that co-cultures immune cells with stem cells, returning educated cells to the circulation. Throne has pursued multiple phase 2 clinical investigations, including FDA-approved INDs, to evaluate Stem Cell Educator therapy for type 1 diabetes, alopecia areata, and severe COVID-19, and reports safety and efficacy signals across international multicenter trials involving hundreds of patients aged wide ranges of early childhood to older adulthood. Its work positions Throne within the biotechnology research sector as a contributor to immune-modulation strategies intended to tackle autoimmune dysfunction at its roots. The company is based in Paramus, New Jersey, and operates with a small team spanning specialized research and clinical development activities. A recent development noted is Throne’s public Regulation Crowdfunding launch to support its ongoing clinical programs.

Sign up for free to view info

Email Format Employee directory